Skip to main content

Find Clinical Trials

Home
Conditions
Gastric Adenocarcinoma

Clinical trial condition

Gastric Adenocarcinoma

Explore clinical trials studying Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

200 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Gastric Adenocarcinoma trial results

Not yet recruiting

A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer

NCT07507526

Conditions: Gastric Adenocarcinoma
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

An Observational Study on Gastric Cancer in High-risk Individuals

NCT07438418

Conditions: Gastric Adenocarcinoma
Locations: People's Hospital of Tongling City Tongling, China

View Trial Details

Not yet recruiting

Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study

NCT07266025

Conditions: Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Immunotherapy, +2 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

NCT07252661

Conditions: Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Diseases, +44 more
Locations: Not specified

View Trial Details

Not yet recruiting

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

NCT06942767

Conditions: Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +4 more
Locations: Not specified

View Trial Details

Not yet recruiting

Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer

NCT06888037

Conditions: First-line Therapy, Fruquintinib, GEJ Adenocarcinoma, +3 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer

NCT06871527

Conditions: Digestive System Diseases, Digestive System Neoplasms, Fruquintinib, +11 more
Locations: The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients

NCT06857786

Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Beijing Gaobo Hospital Beijing, Beijing Municipality, China

Nanjing Gulou Hospital Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma

NCT06586294

Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Locations: Zhejiang Cancer Hospital Hanzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer

NCT06454435

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +8 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China

View Trial Details